78 research outputs found
Calmodulin Transduces Ca<sup>2+</sup> Oscillations into Differential Regulation of Its Target Proteins
Diverse physiological processes are regulated differentially
by Ca<sup>2+</sup> oscillations through the common regulatory hub
calmodulin. The capacity of calmodulin to combine specificity with
promiscuity remains to be resolved. Here we propose a mechanism based
on the molecular properties of calmodulin, its two domains with separate
Ca<sup>2+</sup> binding affinities, and target exchange rates that
depend on both target identity and Ca<sup>2+</sup> occupancy. The
binding dynamics among Ca<sup>2+</sup>, Mg<sup>2+</sup>, calmodulin,
and its targets were modeled with mass-action differential equations
based on experimentally determined protein concentrations and rate
constants. The model predicts that the activation of calcineurin and
nitric oxide synthase depends nonmonotonically on Ca<sup>2+</sup>-oscillation
frequency. Preferential activation reaches a maximum at a target-specific
frequency. Differential activation arises from the accumulation of
inactive calmodulin-target intermediate complexes between Ca<sup>2+</sup> transients. Their accumulation provides the system with hysteresis
and favors activation of some targets at the expense of others. The
generality of this result was tested by simulating 60 000 networks
with two, four, or eight targets with concentrations and rate constants
from experimentally determined ranges. Most networks exhibit differential
activation that increases in magnitude with the number of targets.
Moreover, differential activation increases with decreasing calmodulin
concentration due to competition among targets. The results rationalize
calmodulin signaling in terms of the network topology and the molecular
properties of calmodulin
Fluorescent Filter-Trap Assay for Amyloid Fibril Formation Kinetics in Complex Solutions
Amyloid fibrils are the most distinct
components of the plaques
associated with various neurodegenerative diseases. Kinetic studies
of amyloid fibril formation shed light on the microscopic mechanisms
that underlie this process as well as the contributions of internal
and external factors to the interplay between different mechanistic
steps. Thioflavin T is a widely used noncovalent fluorescent probe
for monitoring amyloid fibril formation; however, it may suffer from
limitations due to the unspecific interactions between the dye and
the additives. Here, we present the results of a filter-trap assay
combined with the detection of fluorescently labeled amyloid β
(Aβ) peptide. The filter-trap assay separates formed aggregates
based on size, and the fluorescent label attached to Aβ allows
for their detection. The times of half completion of the process (<i>t</i><sub>1/2</sub>) obtained by the filter-trap assay are comparable
to values from the ThT assay. High concentrations of human serum albumin
(HSA) and carboxyl-modified polystyrene nanoparticles lead to an elevated
ThT signal, masking a possible fibril formation event. The filter-trap
assay allows fibril formation to be studied in the presence of those
substances and shows that Aβ fibril formation is kinetically
inhibited by HSA and that the amount of fibrils formed are reduced.
In contrast, nanoparticles exhibit a dual-behavior governed by their
concentration
Effects of Polyamino Acids and Polyelectrolytes on Amyloid β Fibril Formation
The
fibril formation of the neurodegenerative peptide amyloid β
(Aβ42) is sensitive to solution conditions, and several proteins
and peptides have been found to retard the process. Aβ42 fibril
formation was followed with ThT fluorescence in the presence of polyamino
acids (poly-glutamic acid, poly-lysine, and poly-threonine) and other
polymers (polyÂ(acrylic acid), polyÂ(ethylenimine), and polyÂ(diallyldimethylammonium
chloride). An accelerating effect on the Aβ42 aggregation process
is observed from all positively charged polymers, while no effect
is seen from the negative or neutral polymers. The accelerating effect
is dependent on the concentration of positive polymer in a highly
reproducible manner. Acceleration is observed from a 1:500 polymer
to Aβ42 weight ratio and up. Polyamino acids and the other polymers
exert quantitatively the same effect at the same concentrations based
on weight. Fibrils are formed in all cases as verified by transmission
electron microscopy. The concentrations of polymers required for acceleration
are too low to affect the Aβ42 aggregation process through increased
ionic strength or molecular crowding effects. Instead, the acceleration
seems to arise from the locally increased Aβ42 concentration
near the polymers, which favors association and affects the electrostatic
environment of the peptide
Binding of Human C4BP to S. pyogenes Strains of Different M Types
<p>Strains of the M types indicated were analyzed for ability to bind radiolabelled C4BP. Upper panel: OF<sup>+</sup> strains. Lower panel: OF<sup>−</sup> strains. Only strains that bound Fg, as determined in parallel tests, were used for the analysis because binding of Fg is a characteristic property of S. pyogenes isolates expressing members of the M protein family. Binding is expressed as percent of added radioactivity. The threshold for binding of C4BP was set at ≥10% binding (dashed line). Background binding to an M-negative strain (~3%) has been subtracted. All strains were tested at least twice, with duplicate samples, and the results were highly reproducible. For each strain, data from one experiment are shown. The data include binding data for one allelic variant per M type, except that data for both M4 and M4.1 are included. For strains of some M types, several allelic variants were tested and in most cases these strains did not differ in ability to bind C4BP (unpublished data).</p
Sequence Analysis of C4BP-Binding HVRs and Site-Specific Mutagenesis in M22
<div><p>(A) Sequence logo of C4BP-binding HVRs. The logo was generated from the seven C4BP-binding HVRs aligned in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.0020047#ppat-0020047-g001" target="_blank">Figure 1</a>B, using WebLogo (<a href="http://weblogo.berkeley.edu" target="_blank">http://weblogo.berkeley.edu</a>). Only regions in the HVRs corresponding to the shortest known C4BP-binding region in M22 (residues 1–39) were used to create the logo. These regions are demarcated by the vertical hatched lines in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.0020047#ppat-0020047-g001" target="_blank">Figure 1</a>B. In the logo, each column in the alignment is represented by a stack of letters, with the height of each letter proportional to the observed frequency of the corresponding residue at that position, while the overall height of each stack is proportional to the sequence conservation at that position [<a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.0020047#ppat-0020047-b063" target="_blank">63</a>]. The sequence of the M4.1 HVR was included in the generation of the logo, although it is virtually identical to M4, because the single residue difference between these two HVRs was important for the conclusion that the different HVRs completely lack residue identities (see text). The numbering below the logo refers to residue numbers in the M22 protein and putative coiled-coil heptads (a–g) in M22 are indicated. Asterisks show the position of four M22 residues (L21, E24, L28, and E31) analyzed by site-specific mutagenesis.</p><p>(B) Helical wheel representation of a dimeric coiled-coil [<a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.0020047#ppat-0020047-b042" target="_blank">42</a>]. The sequence of the L21–E31 region of M22 is included, with asterisks above residues L21, E24, L28, and E31, which were analyzed by site-specific mutagenesis and are located within the predicted coiled-coil region. The positions of residues within putative coiled-coil heptads (a–g) are indicated.</p><p>(C–E) The four mutant M22 proteins indicated, constructed by site-specific mutagenesis, and the wild-type (wt) M22 protein, were expressed in <i>S. pyogenes,</i> and the strains were analyzed for surface expression of the proteins and ability to bind C4BP. The genes encoding the proteins were present on plasmid pLZ12Spec, carried by an M-negative strain. This M-negative strain also served as negative control. (C) and (D) show that the different proteins were expressed normally on the bacterial surface (see text). (E) shows that mutants L21A and L28A had completely lost C4BP-binding ability, while mutants E24A and E31A were unaffected. The results shown in (C–E) are based on three separate experiments with duplicate samples and are presented as means ± SD.</p></div
Characterization of the C4BP-Binding HVR in M114
<div><p>(A) The HVR of M114 is a distinct protein domain that binds C4BP with high specificity. A dimerized synthetic peptide, derived from the 52 N-terminal residues in M114 and designated M114-N, was immobilized in a column. Whole human serum was passed through the column, which was washed and eluted. Control columns contained the C4BP-binding M22-N peptide or the nonbinding M5-N peptide. The eluates, and human serum, were analyzed by SDS-PAGE, as indicated. The ~70 kDa polypeptide present in the eluates from the M22-N and M114-N columns was identified as the C4BP α-chain by Western blot analysis with specific antiserum (not shown).</p><p>(B) The M114 and M22 proteins bind to the same region in C4BP. The peptides indicated were used to inhibit the binding of radiolabelled M22 protein to C4BP immobilized in microtiter wells. Data from three separate experiments with duplicate samples, presented as means ± SD.</p></div
Charge Dependent Retardation of Amyloid β Aggregation by Hydrophilic Proteins
The
aggregation of amyloid β peptides (Aβ) into amyloid fibrils
is implicated in the pathology of Alzheimer’s disease. In light
of the increasing number of proteins reported to retard Aβ fibril
formation, we investigated the influence of small hydrophilic model
proteins of different charge on Aβ aggregation kinetics and
their interaction with Aβ. We followed the amyloid fibril formation
of Aβ40 and Aβ42 using thioflavin T fluorescence in the
presence of six charge variants of calbindin D<sub>9k</sub> and single-chain
monellin. The formation of fibrils was verified with transmission
electron microscopy. We observe retardation of the aggregation process
from proteins with net charge +8, +2, −2, and −4, whereas
no effect is observed for proteins with net charge of −6 and
−8. The single-chain monellin mutant with the highest net charge,
scMN+8, has the largest retarding effect on the amyloid fibril formation
process, which is noticeably delayed at as low as a 0.01:1 scMN+8
to Aβ40 molar ratio. scMN+8 is also the mutant with the fastest
association to Aβ40 as detected by surface plasmon resonance,
although all retarding variants of calbindin D<sub>9k</sub> and single-chain
monellin bind to Aβ40
The HVRs of M4.1 and M114 Bind C4BP
<div><p>Fusion proteins, derived from the HVR of M4.1 or M114 and the C-terminal part of M5, were expressed in the M-negative strain S. pyogenes ΔM5 using genes carried on plasmid pLZ12Spec. Controls included a strain expressing the C4BP-binding fusion protein M22<sup>57</sup>–M5, a strain expressing the non–C4BP-binding M5 protein, and the M-negative strain ΔM5.</p><p>(A) Surface expression analyzed with rabbit antibodies directed against the C-repeat region of M5. Bound antibodies were detected with radiolabelled protein A. Binding of protein A to the M22<sup>57</sup>–M5 strain, incubated with antiserum diluted ×10<sup>2</sup>, was defined as 100%. The M5-negative strain ΔM5 served as negative control.</p><p>(B) Binding of radiolabelled C4BP. Binding at the highest bacterial concentration to the control expressing M22<sup>57</sup>–M5 was defined as 100%. The non–C4BP-binding M5 strain served as negative control. All data in (A) and (B) are based on three separate experiments with duplicate samples, and are presented as means ± SD.</p></div
Single Amino Acid Changes Not Affecting C4BP Binding Cause Major Antigenic Changes in the HVR of M22
<div><p>(A) Schematic representation of an inhibition test used to analyze the antigenic properties of mutant M22 proteins expressed on the surface of <i>S. pyogenes.</i> The test was based on the binding of mouse anti–M22-N to pure M22 protein immobilized in microtiter wells. This binding was inhibited with whole S. pyogenes bacteria expressing mutant M22 proteins.</p><p>(B) Ability of S. pyogenes strains expressing the M22 mutants E24A and E31A to cause inhibition. The positive control expressed the wild-type M22 protein and the negative control lacked M protein. As compared to the positive control, 50% inhibition (dashed line) required ~30-fold more bacteria expressing either of the mutant proteins. Results based on three separate experiments with duplicate samples, presented as means ± SD.</p></div
- …